Biomedical Technology

OrbusNeich Medical Company Limited

🌍 Official Website 🏢 HKSTP Source
68 Potential

Decision Maker

Natalie Lo
info.hk@orbusneich.com
28022288
Units 303 and 305, Building 20E, No. 20 Science Park East Avenue, Pak Shek Kok, Hong Kong Science Park, Hong Kong Hong Kong
Raw Description
OrbusNeich is a healthcare company passionate in designing and delivering innovative solutions for the treatment of vascular diseases to improve patients’ lives. | Our goals are guided by Integrity, Passion, Innovation and Performance, the four core values that define the company’s fundamental beliefs. Since 2005, we have utilised our innovative product technologies and become a global pioneer in the provision of life-changing solutions, by offering an extensive portfolio of products that set industry benchmarks. | Headquartered in Hong Kong with manufacturing facilities in Shenzhen and the Netherlands, OrbusNeich distributes products in over 60 countries through direct sales and distributor partnerships. | Description | OrbusNeich pioneers life-changing technologies || Our Beliefs | OrbusNeich is a healthcare company passionate in designing and delivering innovative solutions | Product | OrbusNeich works together with the medical community to develop state-of-the-art technologies to improve patients’ lives. | Our innovative range of devices are designed to help restore blood flow to blood vessels. We thrive in providing healthcare professionals and patients with best-in-class devices to simplify the treatment of complex lesions. Our extensive range of products includes the world’s first and only pro-healing Dual Therapy Stent, COMBO Plus, as well as multiple conventional and specialty catheters for coronary and peripheral treatment.

Strategic Analysis

Executive Brief

OrbusNeich is a global leader in interventional cardiology and vascular solutions, specializing in high-complexity devices such as the COMBO Plus Dual Therapy Stent and specialty balloon catheters. Their engineering focus centers on biocompatibility, drug-elution precision, and navigating complex vascular lesions. 6C can pivot their roadmap from "conventional" coatings to ultra-performance Nanocrystalline Diamond (NCD) and Boron Doped Diamond (BDD) to enhance device longevity and diagnostic capability.

Strategic Fit & Lead Score

Lead Score: 68/100 (Adjacent Tech - High Potential)

Why this Score? While OrbusNeich currently relies on polymer and drug-eluting coatings, the medical device industry is shifting toward "active" and "ultra-biocompatible" surfaces. 6C’s MPCVD technology offers a leap in surface engineering that solves the fundamental limitations of polymer-based stents, such as delamination and late-stage thrombosis. Additionally, their manufacturing facilities in Shenzhen and the Netherlands are prime candidates for 6C's custom MPCVD system integration for high-volume component coating.

6C Solutions Proposal

Application Area 6C Solution Technical Value Prop
Hemocompatible Coatings Nanocrystalline Diamond (NCD) MPCVD diamond is chemically inert and mimics the smoothness of vascular endothelium. It provides a non-thrombogenic surface that reduces the risk of blood clots compared to traditional metallic or polymer surfaces.
Smart Catheters BDD Micro-Electrodes Integrate Boron Doped Diamond sensors at catheter tips for real-time, in-vivo electrochemical sensing of pH, oxygen levels, or specific biomarkers during lesion crossing.
Low-Friction Navigation PCD Thin-Film Coating Apply ultra-smooth (Ra < 1nm) diamond coatings to guidewires and catheter hubs to drastically reduce the coefficient of friction, enabling easier navigation through complex, calcified lesions.
Precision Micromachining Diamond-Tipped Tooling Supply PCD-coated micro-cutters and drills for the high-precision manufacturing of Nitinol stent struts, ensuring burr-free edges and higher structural integrity.
Drug Delivery Surfaces Functionalized Diamond Use 6C's process recipes to create porous or functionalized diamond surfaces that allow for more stable and controlled drug-loading than traditional polymer carriers.

Engagement Hooks

  • Technical Question: "How is OrbusNeich addressing the engineering trade-off between coating thickness and delamination in your specialty catheters, and have you explored sp3-bonded carbon as a zero-wear alternative to polymers?"
  • Value Statement: "6C can transform your vascular devices from passive implants into active diagnostic tools using MPCVD diamond, providing the world's most biocompatible and friction-less interface for complex lesion treatment."

Material Advantage Comparison

  • Biocompatibility: Diamond is 100% carbon-based (sp3), leading to significantly lower inflammatory responses than cobalt-chromium or stainless steel.
  • Hardness: > 80 GPa, preventing any surface degradation or particulate release during deployment in calcified vessels.
  • Thermal Conductivity: > 2000 W/mK; while less critical for stents, it allows for rapid sterilization and advanced thermal-based sensing at the catheter tip.
  • Chemical Stability: Diamond is impervious to all bodily fluids and pharmacological agents, ensuring the structural base of the stent never degrades.